ConductScience.org, home

Trial · NCT02207621

Adverse events168

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherVital Dye Staining Cornea PresentInvestigationsTimolol Maleate Ophthalmic Solution 0.5% BID14251
otherVital Dye Staining Cornea PresentInvestigationsAR-13324 Ophthalmic Solution 0.02% BID17253
seriousCoronary Artery DiseaseCardiac disordersAR-13324 Ophthalmic Solution 0.02% & Placebo2251
seriousCoronary Artery DiseaseCardiac disordersTimolol Maleate Ophthalmic Solution 0.5% BID0251
seriousCoronary Artery DiseaseCardiac disordersAR-13324 Ophthalmic Solution 0.02% BID1253
seriousMyocardial InfarctionCardiac disordersAR-13324 Ophthalmic Solution 0.02% & Placebo2251
seriousMyocardial InfarctionCardiac disordersTimolol Maleate Ophthalmic Solution 0.5% BID1251
seriousMyocardial InfarctionCardiac disordersAR-13324 Ophthalmic Solution 0.02% BID1253
seriousAtrial FibrillationCardiac disordersAR-13324 Ophthalmic Solution 0.02% & Placebo2251
seriousAtrial FibrillationCardiac disordersTimolol Maleate Ophthalmic Solution 0.5% BID0251
seriousAtrial FibrillationCardiac disordersAR-13324 Ophthalmic Solution 0.02% BID0253
seriousAtrial FlutterCardiac disordersAR-13324 Ophthalmic Solution 0.02% & Placebo1251
seriousAtrial FlutterCardiac disordersTimolol Maleate Ophthalmic Solution 0.5% BID0251
seriousAtrial FlutterCardiac disordersAR-13324 Ophthalmic Solution 0.02% BID0253
seriousBradycardiaCardiac disordersAR-13324 Ophthalmic Solution 0.02% & Placebo1251
seriousBradycardiaCardiac disordersTimolol Maleate Ophthalmic Solution 0.5% BID0251
seriousBradycardiaCardiac disordersAR-13324 Ophthalmic Solution 0.02% BID0253
seriousBreast CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)AR-13324 Ophthalmic Solution 0.02% & Placebo1251
seriousBreast CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)Timolol Maleate Ophthalmic Solution 0.5% BID0251
seriousBreast CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)AR-13324 Ophthalmic Solution 0.02% BID0253

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02207621/events?page=3